Skip to content

A pilot study of thalidomide therapy for alcoholic hepatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN40686096
Enrollment
Unknown
Registered
2005-09-30
Start date
2006-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholic hepatitis Digestive System Alcoholic liver disease

Interventions

Patients referred to the Liver Unit for management of acute alcoholic hepatitis will be invited to participate in the trial provided that they fulfill inclusion criteria according to our proposed prot

Sponsors

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Not provided at time of registration

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Survival or death, since severe AH carries a mortality of 50% within two months.

Secondary

MeasureTime frame
1. Onset of complications such as bacterial or fungal sepsis 2. Renal failure 3. Gastrointestinal haemorrhage

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026